Stroke Patients With Prediabetes Benefit From Pioglitazone

The insulin-sensitizing agent pioglitazone (Actos) appeared effective for secondary prevention in stroke patients with prediabetes, according to a post hoc analysis of the IRIS randomized clinical trial reported here.

Source: Stroke Patients With Prediabetes Benefit From Pioglitazone

About the Author

cloudways

Stephanie Figon, MS, RDN, LD

Founder of NutriScape.NET. As a dietitian since 1992, Steph Figon has had experiences in consulting, 15 years in clinical, and has operated a private practice nutrition counseling office for since 2011. The RDNutriScape Instagram

Tags:

Related Posts